These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38891897)

  • 1. Case Report of Suspected Gonadal Mosaicism in
    Zsigmond A; Till Á; Bene J; Czakó M; Mikó A; Hadzsiev K
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Novel
    Benvenuto M; Palumbo P; Di Muro E; Perrotta CS; Mazza T; Mandarà GML; Palumbo O; Carella M
    Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
    Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
    Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equivalent missense variant in the FOXP2 and FOXP1 transcription factors causes distinct neurodevelopmental disorders.
    Sollis E; Deriziotis P; Saitsu H; Miyake N; Matsumoto N; Hoffer MJV; Ruivenkamp CAL; Alders M; Okamoto N; Bijlsma EK; Plomp AS; Fisher SE
    Hum Mutat; 2017 Nov; 38(11):1542-1554. PubMed ID: 28741757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Joint contractures is a recurrent clinical feature of individuals with neurodevelopmental disorder due to FOXP1 likely gene disruptive variants.
    Peduto C; Cappuccio G; Zeuli R; Zanobio M; Torella A; Alkuraya FS; Joss S; Daolio C; Spinelli AM; Zampieri S; ; Nigro V; Brunetti-Pierri N
    Am J Med Genet A; 2024 Nov; 194(11):e63713. PubMed ID: 38924631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A de novo FOXP1 variant in a patient with autism, intellectual disability and severe speech and language impairment.
    Lozano R; Vino A; Lozano C; Fisher SE; Deriziotis P
    Eur J Hum Genet; 2015 Dec; 23(12):1702-7. PubMed ID: 25853299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective investigation of FOXP1 syndrome.
    Siper PM; De Rubeis S; Trelles MDP; Durkin A; Di Marino D; Muratet F; Frank Y; Lozano R; Eichler EE; Kelly M; Beighley J; Gerdts J; Wallace AS; Mefford HC; Bernier RA; Kolevzon A; Buxbaum JD
    Mol Autism; 2017; 8():57. PubMed ID: 29090079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel FOXP1 pathogenic variants in two Indian subjects with syndromic intellectual disability.
    Moirangthem A; Phadke SR
    Am J Med Genet A; 2021 Apr; 185(4):1324-1327. PubMed ID: 33427368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenic missense mutation pattern of forkhead box genes in neurodevelopmental disorders.
    Han L; Chen M; Wang Y; Wu H; Quan Y; Bai T; Li K; Duan G; Gao Y; Hu Z; Xia K; Guo H
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00789. PubMed ID: 31199603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. De novo mutations in FOXP1 in cases with intellectual disability, autism, and language impairment.
    Hamdan FF; Daoud H; Rochefort D; Piton A; Gauthier J; Langlois M; Foomani G; Dobrzeniecka S; Krebs MO; Joober R; Lafrenière RG; Lacaille JC; Mottron L; Drapeau P; Beauchamp MH; Phillips MS; Fombonne E; Rouleau GA; Michaud JL
    Am J Hum Genet; 2010 Nov; 87(5):671-8. PubMed ID: 20950788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole genome sequencing identifies a de novo 2.1 Mb balanced paracentric inversion disrupting FOXP1 and leading to severe intellectual disability.
    Vuillaume ML; Cogné B; Jeanne M; Boland A; Ung DC; Quinquis D; Besnard T; Deleuze JF; Redon R; Bézieau S; Laumonnier F; Toutain A
    Clin Chim Acta; 2018 Oct; 485():218-223. PubMed ID: 29969624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A De Novo FOXP1 Truncating Mutation in a Patient Originally Diagnosed as C Syndrome.
    Urreizti R; Damanti S; Esteve C; Franco-Valls H; Castilla-Vallmanya L; Tonda R; Cormand B; Vilageliu L; Opitz JM; Neri G; Grinberg D; Balcells S
    Sci Rep; 2018 Jan; 8(1):694. PubMed ID: 29330474
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Meerschaut I; Rochefort D; Revençu N; Pètre J; Corsello C; Rouleau GA; Hamdan FF; Michaud JL; Morton J; Radley J; Ragge N; García-Miñaúr S; Lapunzina P; Bralo MP; Mori MÁ; Moortgat S; Benoit V; Mary S; Bockaert N; Oostra A; Vanakker O; Velinov M; de Ravel TJ; Mekahli D; Sebat J; Vaux KK; DiDonato N; Hanson-Kahn AK; Hudgins L; Dallapiccola B; Novelli A; Tarani L; Andrieux J; Parker MJ; Neas K; Ceulemans B; Schoonjans AS; Prchalova D; Havlovicova M; Hancarova M; Budisteanu M; Dheedene A; Menten B; Dion PA; Lederer D; Callewaert B
    J Med Genet; 2017 Sep; 54(9):613-623. PubMed ID: 28735298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXP1 mutations cause intellectual disability and a recognizable phenotype.
    Le Fevre AK; Taylor S; Malek NH; Horn D; Carr CW; Abdul-Rahman OA; O'Donnell S; Burgess T; Shaw M; Gecz J; Bain N; Fagan K; Hunter MF
    Am J Med Genet A; 2013 Dec; 161A(12):3166-75. PubMed ID: 24214399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three Japanese patients with 3p13 microdeletions involving FOXP1.
    Yamamoto-Shimojima K; Okamoto N; Matsumura W; Okazaki T; Yamamoto T
    Brain Dev; 2019 Mar; 41(3):257-262. PubMed ID: 30424912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and genetic analysis of three children with mental retardation, language impairment and autistic features due to de novo variants of FOXP1 gene].
    Hua R; Xu X; Wu D; Yang L; Yuan J; Zhu J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Dec; 38(12):1194-1198. PubMed ID: 34839505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical phenotype of FOXP1 syndrome: parent-reported medical signs and symptoms in 40 individuals.
    Koene S; Ropers FG; Wieland J; Rybak T; Wildschut F; Berghuis D; Morgan A; Trelles MP; Scheepe JR; Bökenkamp R; Peeters-Scholte CMPCD; Braden R; Santen GWE
    J Med Genet; 2024 Mar; 61(4):399-404. PubMed ID: 38123995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient with a heterozygous pathogenic variant in CSNK2A1 gene: A new case to update the Okur-Chung neurodevelopmental syndrome.
    Blanc A; Bonnet C; Wandzel M; Roth V; Duffourd Y; Safraou H; Leheup B; Muller F; D Colne J; Feillet F; Schmitt E; Castro M; Savatt J; Burcheri A; Nemos C; Philippe C; Lambert L
    Am J Med Genet A; 2024 Sep; 194(9):e63642. PubMed ID: 38711237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXP1 syndrome: a review of the literature and practice parameters for medical assessment and monitoring.
    Lozano R; Gbekie C; Siper PM; Srivastava S; Saland JM; Sethuram S; Tang L; Drapeau E; Frank Y; Buxbaum JD; Kolevzon A
    J Neurodev Disord; 2021 Apr; 13(1):18. PubMed ID: 33892622
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.